Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preconditioning in Open Heart Surgery
NCT03097692Completed
- Sponsor
- Assiut University
- Start
- May 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sevoflurane in cardiovascular diseases (CVD) (2 arms), sponsored by Assiut University. Primary endpoint: Change of Neutrophil lymphocyte ratio. Started May 2016; status: completed.
02
Drugs
sevoflurane
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT03097692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03097692.